1. Stocks
  2. Piramal Pharma Ltd.
  3. Swot
swot-logo

Piramal Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Piramal Pharma Ltd. has 12 Strengths, 13 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Mid-range Performer (DVM)

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Promoter decreasing their shareholding

PE higher than Industry PE

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

High PE (PE > 40)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Declining Net Cash Flow : Companies not able to generate net cash

Weak Momentum: Price below Short, Medium and Long Term Averages

Profit to Loss Companies

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

RSI indicating price weakness

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Street Favorite: High Analyst Rating with at least 20% upside

Highest FII stock holdings

MFs decreased their shareholding last quarter

Rising Delivery Percentage Compared to Prev Day

Bullish or Bearish Candlestick Strength - Indices

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)